The Japanese PV device market will see modest growth through 2028, driven primarily by the expanding PAD population and the availability of new premium-priced products, such as DES and DCBs, that are backed by strong clinical data. However, market revenues will be hindered by ASP declines caused by biennial reimbursement cuts by the MHLW over the forecast period.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PV devices in Japan across a 10-year period.


A meta-analysis was published in 2018 that showed an increased risk of death associated with paclitaxel-coated balloons and stents.

How has this study impacted the Japanese market for DCBs and DES?

How has this study impacted physicians' perception of these products?

Which companies will be affected and how?

What strategies are the concerned companies employing to counteract the effects of the study?

Various DCB and DES manufacturers have invested in clinical trials to expand their offerings in indications such as BTK.

Which trials will impact the adoption of DCBs and DES for the BTK indication?

What has been physicians' preferred approach to treat lesions in the BTK indication?

Premium-priced DCBs for lower extremities have entered the Japanese market and will drive market growth.

Will DCBs or DES become the standard drug-eluting solution for BTK lesions?

Which competitors are likely to enter the DCB market, and which will gain the most market share?

How will DCB uptake affect use of other PV devices, such as stents and standard balloon catheters?

Which new indications will drive growth in the DCB market?

Biennial reimbursement cuts by the MHLW continue to affect the Japanese PV device market.

Which market segments will experience the highest cuts to reimbursement, and why?

In which segments will procedural growth compensate for ASP declines, resulting in market growth?

What are alternative strategies for companies to encourage adoption of premium-priced products?

Table of contents

  • Japan
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Average Currency Exchange Rates
      • Procedures Covered
      • Products Covered
    • Key Report Updates
    • Peripheral Vascular Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Indication (Procedures Only)
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Physician Training and Marketing
        • Distribution and Sales Network
        • Regulatory Environment
        • Market Appeal
        • First-Mover Advantage
      • Market Developments
    • Peripheral Vascular Stent Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Product Improvements and Innovations
        • Physician Training and Marketing
        • First-Mover Advantage
    • PTA Balloon Catheter Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • By Product Type
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
        • Market Appeal
        • Product Improvements and Innovations
    • Embolic Protection Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Chronic Total Occlusion Crossing Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Peripheral Vascular Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Thrombectomy and Thrombolysis Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Improvements and Innovations
    • Surgical Graft Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Bishwjit Ghoshal, MBA

Bishwjit Ghoshal is a senior analyst within the Cardiovascular Medtech Insights team at DRG (Part of Clarivate), specializing in interventional oncology and vascular access device markets. Bishwjit holds a Bachelor's degree in Pharmacy from the University of Delhi and an MBA in Pharmaceutical Marketing from the National Institute of Pharmaceutical Education and Research, Mohali. Follow Bishwjit on twitter: @Bishwjit_DRG


Related Reports

Peripheral Vascular Devices | Medtech 360 | Market Insights | Canada

The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product l...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Latin America

A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in th...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | Asia Pacific (Supplemental)

The Asia Pacific market for PV devices will grow modestly through 2028, fueled by the growing PAD&nbs...

View Details

Peripheral Vascular Devices | Medtech 360 | Market Insights | United States

The US market for PV devices is an evolving market, where a large undiagnosed patient population and innovative product launches will allow for sign...

View Details